AstraZeneca
AZN
#43
Rank
C$433.00 B
Marketcap
C$279.30
Share price
-1.09%
Change (1 day)
36.37%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of December 2025 : C$7.85 Billion

According to AstraZeneca's latest financial reports the company has C$7.85 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$7.86 B-0.83%
2024-12-31C$7.92 B2.01%
2023-12-31C$7.77 B-8.25%
2022-12-31C$8.47 B3.89%
2021-12-31C$8.15 B-19.98%
2020-12-31C$10.19 B25.5%
2019-12-31C$8.11 B6.56%
2018-12-31C$7.62 B33.09%
2017-12-31C$5.72 B-26.68%
2016-12-31C$7.80 B-16.51%
2015-12-31C$9.35 B14.48%
2014-12-31C$8.17 B-22.42%
2013-12-31C$10.53 B28.8%
2012-12-31C$8.17 B-28.71%
2011-12-31C$11.46 B-2.96%
2010-12-31C$11.82 B-1.47%
2009-12-31C$11.99 B124.71%
2008-12-31C$5.33 B-10.17%
2007-12-31C$5.94 B-33.56%
2006-12-31C$8.94 B54.33%
2005-12-31C$5.79 B-8.33%
2004-12-31C$6.32 B23.39%
2003-12-31C$5.12 B-30.78%
2002-12-31C$7.40 B21.58%
2001-12-31C$6.09 B-8.7%
2000-12-31C$6.67 B40.66%
1999-12-31C$4.74 B-9.6%
1998-12-31C$5.24 B204.67%
1997-12-31C$1.72 B-24.71%
1996-12-31C$2.28 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$27.49 B 250.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$15.77 B 100.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$20.49 B 161.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.57 B 34.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$9.94 B 26.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.29 B 82.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$5.21 B-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$24.91 B 217.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$14.59 B 85.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$6.07 B-22.59%๐Ÿ‡ฌ๐Ÿ‡ง UK